Covestor
MRNA icon

Covestor’s Moderna MRNA Stock Holding History

Covestor’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$33K Buy
173
+1
+0.6% +$108 0.02% 919
2026
Q2 		$12K Sell
172
-130
-43% -$6.73K 0.01% 1448
2026
Q1 		$15K Sell
302
-194
-39% -$9.05K 0.01% 1231
2025
Q4 		$15K Buy
496
+55
+12% +$1.49K 0.01% 1401
2025
Q3 		$11K Sell
441
-7
-2% -$195 0.01% 1548
2025
Q2 		$12K Buy
448
+170
+61% +$4.48K 0.01% 1479
2025
Q1 		$8K Buy
278
+3
+1% +$106 0.01% 1629
2024
Q4 		$11K Buy
275
+117
+74% +$5.59K 0.01% 1492
2024
Q3 		$11K Buy
158
+2
+1% +$184 0.01% 1501
2024
Q2 		$19K Sell
156
-257
-62% -$32.5K 0.01% 1221
2024
Q1 		$44K Sell
413
-272
-40% -$27.4K 0.03% 930
2023
Q4 		$68K Sell
685
-630
-48% -$53K 0.05% 715
2023
Q3 		$136K Buy
1,315
+1,152
+707% +$129K 0.1% 262
2023
Q2 		$20K Buy
163
+26
+19% +$3.47K 0.02% 1139
2023
Q1 		$21K Sell
137
-12
-8% -$1.98K 0.02% 986
2022
Q4 		$27K Sell
149
-137
-48% -$22.4K 0.02% 948
2022
Q3 		$34K Sell
286
-971
-77% -$147K 0.03% 847
2022
Q2 		$179K Buy
1,257
+58
+5% +$8.29K 0.14% 139
2022
Q1 		$207K Buy
1,199
+836
+230% +$141K 0.14% 143
2021
Q4 		$92K Buy
+363
New +$106K 0.13% 202

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return

Covestor's MRNA Position: Q3 2026 in Review

Covestor increased its Moderna (MRNA) stake by 0.58% in Q3 2026, buying an estimated $108 and bringing the position to 173 shares worth $33K. The position accounts for 0.02% of the portfolio, ranked #919.

Covestor first reported a position in MRNA in Q4 2021 and has held it in 20 quarters since. The position peaked at $207K in Q1 2022. 789 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Covestor held 173 shares of Moderna worth $33K as of Q3 2026.
  • Covestor bought 1 Moderna share in Q3 2026, an estimated $108.
  • Moderna made up 0.02% of Covestor's portfolio in Q3 2026, its #919 holding.
  • Covestor first reported a position in Moderna in Q4 2021 and has held it in 20 quarters since.
  • Covestor's Moderna position peaked at $207K in Q1 2022.
  • 789 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.